Market Overview:
The global syndromic multiplex diagnostic market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of infectious diseases, growing demand for syndromic testing, and technological advancements in diagnostics. Based on type, the global syndromic multiplex diagnostic market is segmented into gastrointestinal syndromic multiplex diagnostic, central nervous system syndromic multiplex diagnostic, and others. The gastrointestinal syndrome segment is expected to account for the largest share of the global Syndromic Multiplex Diagnostic Market by type during the forecast period. This can be attributed to factors such as rising incidence of foodborne illnesses and increasing demand for point-of-care diagnostics tests. Based on application, hospitals are expected to account for the largest share of the global Syndromic Multiplex Diagnostic Market by application duringthe forecast period.
Product Definition:
A syndromic multiplex diagnostic is a type of diagnostic test that can simultaneously detect multiple diseases or conditions. This type of test can be important for several reasons. First, it can help to improve the accuracy of diagnosis by allowing doctors to identify more than one condition at a time. Additionally, syndromic multiplex diagnostics can help to speed up the process of diagnosis by enabling doctors to evaluate patients for a variety of conditions at once. This type of testing can be especially useful in cases where the patient has symptoms that could potentially be caused by several different diseases or conditions.
Gastrointestinal Syndromic Multiplex Diagnostic:
Gastrointestinal syndromic multiplex diagnostic (GSMD) is a new and emerging technology that uses multiplexed targeted agents to diagnose gastrointestinal disorders. These are noninvasive techniques that help in the detection of various GI diseases by identifying biomarkers. The most commonly used biomarkers for diagnosis include tumor markers, such as CA19-9, CA242, and CEA; inflammation markers, such as sICOS; infection markers including H.
Central Nervous System Syndromic Multiplex Diagnostic:
The global Central Nervous System (CNS) syndromic multiplex diagnostic market size was valued at USD 4.0 billion in 2016 and is expected to grow at a CAGR of XX% over the forecast period. The rising prevalence of neurological disorders, such as Alzheimer’s disease, Parkinson’s disease, dementia including vascular dementia and frontotemporal dementia along with other CNS-related diseases is driving the growth of this market globally.
Application Insights:
Based on application, the global syndromic multiplex diagnostic market is segmented into hospitals, diagnostics laboratories, research institutes and others. Hospitals were estimated to be the largest revenue-generating centers in 2017. The key factor contributing to this growth is an increase in the number of patients with similar symptoms across different regions who are suspected to have contracted a new disease. This has resulted in an increased demand for diagnosis that can be performed rapidly and at low cost.
The use of syndromic diagnosis for other applications such as food & waterborne diseases or animal infections also contributes significantly towards increasing market share of this segment over others owing to its high specificity and sensitivity which makes it suitable for various applications including outbreak detection & control among others (Kumar et al., 2016).
Regional Analysis:
North America dominated the global syndromic multiplex diagnostic market in 2016. This can be attributed to the presence of key players, high adoption rate of advanced technologies, and favorable reimbursement policies & government initiatives. For instance, in 2017 FDA approved COVID-19 for use as a biomarker test for COVID-19 rapid diagnosis.
Asia Pacific is expected to grow at a lucrative CAGR during the forecast period owing to increasing incidence rates coupled with growing awareness about early diagnosis and rising disposable income levels among people in this region.
Growth Factors:
- Increasing incidence of infectious diseases: The incidence of infectious diseases is increasing at a rapid pace across the globe. This is primarily attributed to the changing lifestyle and environmental conditions. This, in turn, is fueling the demand for syndromic multiplex diagnostic tests as they help in early diagnosis and treatment of infections.
- Rising awareness about syndromic testing: There is a growing awareness among people about syndromic testing and its benefits over traditional diagnostic methods. This is helping to boost the demand for syndromic multiplex diagnostics globally.
- Technological advancements: The technological advancements in diagnostics are aiding in development of novel and more efficient syndromic multiplex diagnostic tests. This is propelling the growth of this market worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Syndromic Multiplex Diagnostic Market Research Report
By Type
Gastrointestinal Syndromic Multiplex Diagnostic, Central Nervous System Syndromic Multiplex Diagnostic, Others
By Application
Hospitals, Diagnostics Laboratories, Research Institutes, Others
By Companies
Abbott, Hologic, Bosch, Danaher, Johnson & Johnson, Danaher, Bio-Rad Laboratories, Luminex, bioMérieux, Qiagen, Alveo Technologies, Mesa Biotech, Applied BioCode, Akonni Biosystems, Diagenode Diagnostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
155
Number of Tables & Figures
109
Customization Available
Yes, the report can be customized as per your need.
Global Syndromic Multiplex Diagnostic Market Report Segments:
The global Syndromic Multiplex Diagnostic market is segmented on the basis of:
Types
Gastrointestinal Syndromic Multiplex Diagnostic, Central Nervous System Syndromic Multiplex Diagnostic, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Diagnostics Laboratories, Research Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Hologic
- Bosch
- Danaher
- Johnson & Johnson
- Danaher
- Bio-Rad Laboratories
- Luminex
- bioMérieux
- Qiagen
- Alveo Technologies
- Mesa Biotech
- Applied BioCode
- Akonni Biosystems
- Diagenode Diagnostics
Highlights of The Syndromic Multiplex Diagnostic Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Gastrointestinal Syndromic Multiplex Diagnostic
- Central Nervous System Syndromic Multiplex Diagnostic
- Others
- By Application:
- Hospitals
- Diagnostics Laboratories
- Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Syndromic Multiplex Diagnostic Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Syndromic multiplex diagnostic is a type of genetic testing that uses a panel of tests to identify abnormalities in several different genes. This type of testing can help doctors diagnose and treat conditions such as cancer, heart disease, and diabetes.
Some of the major players in the syndromic multiplex diagnostic market are Abbott, Hologic, Bosch, Danaher, Johnson & Johnson, Danaher, Bio-Rad Laboratories, Luminex, bioM©rieux, Qiagen, Alveo Technologies, Mesa Biotech, Applied BioCode, Akonni Biosystems, Diagenode Diagnostics.
The syndromic multiplex diagnostic market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Syndromic Multiplex Diagnostic Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Syndromic Multiplex Diagnostic Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Syndromic Multiplex Diagnostic Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Syndromic Multiplex Diagnostic Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Syndromic Multiplex Diagnostic Market Size & Forecast, 2018-2028
4.5.1 Syndromic Multiplex Diagnostic Market Size and Y-o-Y Growth
4.5.2 Syndromic Multiplex Diagnostic Market Absolute $ Opportunity
Chapter 5 Global Syndromic Multiplex Diagnostic Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Syndromic Multiplex Diagnostic Market Size Forecast by Type
5.2.1 Gastrointestinal Syndromic Multiplex Diagnostic
5.2.2 Central Nervous System Syndromic Multiplex Diagnostic
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Syndromic Multiplex Diagnostic Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Syndromic Multiplex Diagnostic Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Diagnostics Laboratories
6.2.3 Research Institutes
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Syndromic Multiplex Diagnostic Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Syndromic Multiplex Diagnostic Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Syndromic Multiplex Diagnostic Analysis and Forecast
9.1 Introduction
9.2 North America Syndromic Multiplex Diagnostic Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Syndromic Multiplex Diagnostic Market Size Forecast by Type
9.6.1 Gastrointestinal Syndromic Multiplex Diagnostic
9.6.2 Central Nervous System Syndromic Multiplex Diagnostic
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Syndromic Multiplex Diagnostic Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Diagnostics Laboratories
9.10.3 Research Institutes
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Syndromic Multiplex Diagnostic Analysis and Forecast
10.1 Introduction
10.2 Europe Syndromic Multiplex Diagnostic Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Syndromic Multiplex Diagnostic Market Size Forecast by Type
10.6.1 Gastrointestinal Syndromic Multiplex Diagnostic
10.6.2 Central Nervous System Syndromic Multiplex Diagnostic
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Syndromic Multiplex Diagnostic Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Diagnostics Laboratories
10.10.3 Research Institutes
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Syndromic Multiplex Diagnostic Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Syndromic Multiplex Diagnostic Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Syndromic Multiplex Diagnostic Market Size Forecast by Type
11.6.1 Gastrointestinal Syndromic Multiplex Diagnostic
11.6.2 Central Nervous System Syndromic Multiplex Diagnostic
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Syndromic Multiplex Diagnostic Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Diagnostics Laboratories
11.10.3 Research Institutes
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Syndromic Multiplex Diagnostic Analysis and Forecast
12.1 Introduction
12.2 Latin America Syndromic Multiplex Diagnostic Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Syndromic Multiplex Diagnostic Market Size Forecast by Type
12.6.1 Gastrointestinal Syndromic Multiplex Diagnostic
12.6.2 Central Nervous System Syndromic Multiplex Diagnostic
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Syndromic Multiplex Diagnostic Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Diagnostics Laboratories
12.10.3 Research Institutes
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Syndromic Multiplex Diagnostic Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Syndromic Multiplex Diagnostic Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Syndromic Multiplex Diagnostic Market Size Forecast by Type
13.6.1 Gastrointestinal Syndromic Multiplex Diagnostic
13.6.2 Central Nervous System Syndromic Multiplex Diagnostic
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Syndromic Multiplex Diagnostic Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Diagnostics Laboratories
13.10.3 Research Institutes
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Syndromic Multiplex Diagnostic Market: Competitive Dashboard
14.2 Global Syndromic Multiplex Diagnostic Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Hologic
14.3.3 Bosch
14.3.4 Danaher
14.3.5 Johnson & Johnson
14.3.6 Danaher
14.3.7 Bio-Rad Laboratories
14.3.8 Luminex
14.3.9 bioMérieux
14.3.10 Qiagen
14.3.11 Alveo Technologies
14.3.12 Mesa Biotech
14.3.13 Applied BioCode
14.3.14 Akonni Biosystems
14.3.15 Diagenode Diagnostics
